Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment

Apoptosis

Volumn 16, Issue 7, 2011, Pages 683-695

  Zhang, Chris Z Y ^a   Zhang, H T ^a   Chen, George G ^a   Lai, Paul B S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Bid; Etoposide; HBx; TSA

Indexed keywords

CASPASE 3; CASPASE 8; ETOPOSIDE; HEPATITIS B VIRUS X PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BID; PROTEIN P53; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CYTOPLASM; DRUG SENSITIZATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; LIVER CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASES; CELL DEATH; CELL NUCLEUS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; ETOPOSIDE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GREEN FLUORESCENT PROTEINS; HEP G2 CELLS; HUMANS; HYDROXAMIC ACIDS; LIVER NEOPLASMS; PHOSPHORYLATION; PROTEIN TRANSPORT; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

HEPATITIS B VIRUS;

EID: 80051547554     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0597-x     Document Type: Article

References (47)

1. Bruix J, Boix L, Sala M, Llovet JM (2004) Focus on hepatocellular carcinoma. Cancer Cell 5(3):215-219 (Pubitemid 38402113)
2. Braillon A (2009) Hepatocellular carcinoma and evidence-based surgery. World J Gastroenterol 15(42):5371
3. Cohn AL, Myers JW, Mamus S, Deur C, Nicol S, Hood K, Khan MM, Ilegbodu D, Asmar L (2008) A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma. Invest New Drugs 26(4):381-386
4. Lee JO, Lee KW, Oh DY, Kim JH, Im SA, Kim TY, Bang YJ (2009) Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. Ann Oncol 20(8):1402-1407
5. Yuan JN, Chao Y, Lee WP, Li CP, Lee RC, Chang FY, Yen SH, Lee SD, Whang-Peng J (2008) Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. Med Oncol 25(2):201-206
6. Diao J, Garces R, Richardson CD (2001) X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 12(2-3): 189-205 (Pubitemid 32588145)
7. Hodgson AJ, Keasler VV, Slagle BL (2008) Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res 68(24):10341-10348
8. Wang WH, Hullinger RL, Andrisani OM (2008) Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J Biol Chem 283(37):25455-25467
9. Cheng P, Li Y, Yang L, Wen Y, Shi W, Mao Y, Chen P, Lv H, Tang Q, Wei Y (2009) Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase. Oncol Rep 22(5):1101-1107
10. Cheng AS, Wong N, Tse AM, Chan KY, Chan KK, Sung JJ, Chan HL (2007) RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma. Cancer Lett 253(1):43-52 (Pubitemid 46874725)
11. Cheng AS, Yu J, Lai PB, Chan HL, Sung JJ (2008) COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis. Biochem Biophys Res Commun 374(2):175-180
12. Kuo TC, Chao CC (2010) Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression. Biochem Pharmacol 80(7):1093-1102
13. Chung TW, Lee YC, Kim CH (2004) Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 18(10):1123-1125
14. Cotter TG (2009) Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 9(7):501-507
15. Clohessy JG, Zhuang J, de Boer J, Gil-Gomez G, Brady HJ (2006) Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J Biol Chem 281(9):5750-5759 (Pubitemid 43847674)
16. Ward MW, Rehm M, Duessmann H, Kacmar S, Concannon CG, Prehn JH (2006) Real time single cell analysis of Bid cleavage and Bid translocation during caspase-dependent and neuronal caspase-independent apoptosis. J Biol Chem 281(9):5837-5844 (Pubitemid 43847683)
17. Coradini D, Speranza A (2005) Histone deacetylase inhibitors for treatment of hepatocellular carcinoma. Acta Pharmacol Sin 26(9):1025-1033 (Pubitemid 41296939)
18. Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, Camoratto AM, Evans AE, Brodeur GM (2002) Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 62(22):6462-6466 (Pubitemid 35364107)
19. Wilstermann AM, Bender RP, Godfrey M, Choi S, Anklin C, Berkowitz DB, Osheroff N, Graves DE (2007) Topoisomerase II-drug interaction domains: identification of substituents on etoposide that interact with the enzyme. Biochemistry 46(28): 8217-8225 (Pubitemid 47075961)
20. Treszezamsky AD, Kachnic LA, Feng Z, Zhang J, Tokadjian C, Powell SN (2007) BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II. Cancer Res 67(15):7078-7081 (Pubitemid 47206532)
21. Oh SY, Sohn YW, Park JW, Park HJ, Jeon HM, Kim TK, Lee JS, Jung JE, Jin X, Chung YG, Choi YK, You S, Lee JB, Kim H (2007) Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species mediated damage. Mol Cancer Ther 6(8):2178-2187 (Pubitemid 47294746)
22. Chiu CC, Lin CH, Fang K (2005) Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase- 7-mediated apoptosis. Apoptosis 10(3):643-650 (Pubitemid 40896669)
23. Yin D, Tamaki N, Kokunai T (2000) Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells. J Neurosurg 93(2):289-297 (Pubitemid 30604872)
24. Hwang JH, Kim JY, Cha MR, Ryoo IJ, Choo SJ, Cho SM, Tsukumo Y, Tomida A, Shin-Ya K, Hwang YI, Yoo ID, Park HR (2008) Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator. J Cell Physiol 215(1):243-250 (Pubitemid 351363209)
25. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK (2001) Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1(3):194-202 (Pubitemid 33741894)
26. Henderson C, Mizzau M, Paroni G, Maestro R, Schneider C, Brancolini C (2003) Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem 278(14):12579-12589 (Pubitemid 36800248)
27. Muscolini M, Cianfrocca R, Sajeva A, Mozzetti S, Ferrandina G, Costanzo A, Tuosto L (2008) Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells. Mol Cancer Ther 7(6):1410-1419
28. Hajji N, Wallenborg K, Vlachos P, Nyman U, Hermanson O, Joseph B (2008) Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIFdependent apoptotic cell death in non-small cell lung carcinoma cells. Oncogene 27(22):3134-3144 (Pubitemid 351693171)
29. Sayan BS, Sayan AE, Knight RA, Melino G, Cohen GM (2006) p53 is cleaved by caspases generating fragments localizing to mitochondria. J Biol Chem 281(19):13566-13573 (Pubitemid 43855270)
30. Song G, Chen GG, Yun JP, Lai PB (2009) Association of p53 with Bid induces cell death in response to etoposide treatment in hepatocellular carcinoma. Curr Cancer Drug Targets 9(7):871-880
31. Tang H, Da L, Mao Y, Li Y, Li D, Xu Z, Li F, Wang Y, Tiollais P, Li T, Zhao M (2009) Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology 49(1):60-71
32. Kim HJ, Kim SY, Kim J, Lee H, Choi M, Kim JK, Ahn JK (2008) Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria. IUBMB Life 60(7):473-480
33. Liang X, Liu Y, Zhang Q, Gao L, Han L, Ma C, Zhang L, Chen YH, Sun W (2007) Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol 178(1) :503-510 (Pubitemid 46033634)
34. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH, Harris CC (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 55(24):6012-6016
35. Zhang JL, Zhao WG,WuKL, Wang K, Zhang X, Gu CF, Li Y, Zhu Y, Wu JG (2005) Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin. Arch Virol 150(4):721-741 (Pubitemid 40560821)
36. Lee YI, Kang-Park S, Do SI (2001) The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 276(20):16969-16977
37. Zelivianski S, Spellman M, Kellerman M, Kakitelashvilli V, Zhou XW, Lugo E, Lee MS, Taylor R, Davis TL, Hauke R, Lin MF (2003) ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int J Cancer 107(3):478-485 (Pubitemid 37266470)
38. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC (2005) Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell 19(2):159-170 (Pubitemid 41019664)
39. Nijhara R, Jana SS, Goswami SK, Rana A, Majumdar SS, Kumar V, Sarkar DP (2001) Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J Virol 75(21):10348-10358 (Pubitemid 32948065)
40. Noh EJ, Jung HJ, Jeong G, Choi KS, Park HJ, Lee CH, Lee JS (2004) Subcellular localization and transcriptional repressor activity of HBx on p21(WAF1/Cip1) promoter is regulated by ERK-mediated phosphorylation. Biochem Biophys Res Commun 319(3):738-745 (Pubitemid 38739383)
41. Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish JA (1995) Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response elementdirected transactivation. J Virol 69(3):1851-1859
42. Wang JH, Yun C, Kim S, Chae S, Lee YI, Kim WH, Lee JH, Kim W, Cho H (2008) Reactivation of p53 in cells expressing hepatitis B virus X-protein involves p53 phosphorylation and a reduction of Hdm2. Cancer Sci 99(5):888-893 (Pubitemid 351997589)
43. Okorokov AL, Ponchel F, Milner J (1997) Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53. EMBO J 16(19):6008-6017 (Pubitemid 27427296)
44. Gahr S, Ocker M, Ganslmayer M, Zopf S, Okamoto K, Hartl A, Leitner S, Hahn EG, Herold C (2007) The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. Int J Oncol 31(3):567-576
45. Tan L, Kwok RP, Shukla A, Kshirsagar M, Zhao L, Opipari AW Jr, Liu JR (2011) Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. Cancer 117(4):784-794
46. Zhou X, Richon VM, Wang AH, Yang XJ, Rifkind RA, Marks PA (2000) Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras. Proc Natl Acad Sci USA 97(26): 14329-14333 (Pubitemid 32016575)
47. Barter MJ, Pybus L, Litherland GJ, Rowan AD, Clark IM, Edwards DR, Cawston TE, Young DA (2010) HDAC-mediated control of ERK-and PI3K-dependent TGF-beta-induced extracellular matrix-regulating genes. Matrix Biol 29(7):602-612